Inhibition of L-tyrosine-induced micronuclei production by phenylthiourea in human melanoma cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 446, Issue 2, 1999, Pages 143-148

  Poma, Anna ^a   Bianchini, Stefano ^a   Miranda, Michele ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Human melanoma cell lines; L Tyrosine; Micronuclei; Phenylthiourea

Indexed keywords

PHENYLTHIOUREA; TYROSINE;

AMELANOTIC MELANOMA; APOPTOSIS; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOGENESIS; MELANOMA CELL; MICRONUCLEUS TEST; PRIORITY JOURNAL;

APOPTOSIS; CELL NUCLEUS; CYTOCHALASIN B; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MELANOMA; MELANOMA, AMELANOTIC; MICRONUCLEUS TESTS; MONOPHENOL MONOOXYGENASE; PHENYLTHIOUREA; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0032804137     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00142-4     Document Type: Article

References (23)

1. Hochstein P., Cohen G. The cytotoxicity of melanin precursors. Ann. N.Y. Acad. Sci. 100:1963;876-886.
2. Halaban R., Lerner A.B. Tyrosinase and inhibition of proliferation of melanoma cells and fibroblast. Exp. Cell Res. 108:1977;119-125.
3. Pawelek J.R., Lerner A.B. 5,6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature. 276:1978;627-628.
4. Riley P.A., Sawyer B., Wolff M.A. The melanocytotoxic action of 4-hydroxyanisole. J. Invest. Dermatol. 64:1975;86-89.
5. Wick M.M. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma. Cancer Res. 40:1980;1414-1418.
6. Miranda M., Botti D., Di Cola M. Possible genotoxicity of melanin synthesis intermediates: tyrosinase reaction products interact with DNA in vitro. Mol. Gen. Genet. 193:1984;395-399.
7. Miranda M., Bonfigli A., Zarivi O., Manilla A., Cimini A.M., Arcadi A. Restriction patterns of model DNA treated with 5,6-dihydroxyindole, a potent cytotoxic intermediate of melanin synthesis: effect of u.v. irradiation. Mutagenesis. 2:1987;45-50.
8. Miranda M., Amicarelli F., Bonfigli A., Poma A., Zarivi O., Arcadi A. Mutagenicity test for unstable compounds, such as 5,6-dihydroxyindole, using an Escherichia coli HB101/pBR322 transfection system. Mutagenesis. 5:1990;251-255.
9. Miranda M., Amicarelli F., Poma A., Ragnelli A.M., Scirri C., Aimola P.P. Cyto-genotoxic species leakage within human melanoma melanosomes. Molecular-morphological correlations. Biochem. Mol. Biol. Int. 32(5):1994;913-922.
10. Miranda M., Zarivi O., Amicarelli F., Ragnelli A.M., Aimola P.P., Poma A. Molecular approach to the nucleo-melanosomal interaction in human melanoma cells. J. Neuro-Oncol. 31:1997;185-193.
11. Miranda M., Ligas C., Amicarelli F., D'Alessandro E., Brisdelli F., Poma A. Sister chromatid exchange (SCE) in human melanoma cells as an index of mutagenesis. Mutagenesis. 12(2):1997;233-236.
12. Poste G., Fidler I.J. The patogenesis of cancer metastasis. Nature. 283:1980;139-146.
13. D.A. Robb, Tyrosinase, in: S. Lontie (Ed.), Copper Proteins and Copper Enzymes, Vol. II, CRC Press, Boca Raton, FL, 1984, pp. 207-217.
14. E.J. Tawn, D. Holdsworth, Mutagen-induced chromosome damage in human lymphocytes, in: D.E. Rooney, B.H. Czepulkowski (Eds.), Human Cytogenetics - A Practical Approach, IRL Press, Oxford, 1992, pp. 188-208.
15. Miranda M., Amicarelli F., Poma A., Ragnelli A.M., Arcadi A. Liposome-entrapped tyrosinase: a tool to investigate the regulation of the Raper-Mason pathway. Biochim. Biophys. Acta. 966:1988;276-286.
16. Dominguez I., Panneerselvam N., Escalza P., Natarajan A.T., Cortes F. Adaptive response to radiation damage in human lymphocytes conditioned with hydrogen peroxide as measured by the cytokinesis-block micronucleus technique. Mutat. Res. 301:1993;135-141.
17. Fenech M., Morley A.A. Measurement of micronuclei in lymphocytes. Mutat. Res. 147:1985;29-36.
18. Roser M., Bohm A., Oldigs M., Weichetnthal M., Reimers U., Schmidt-Preuss U. Ultraviolet-induced formation of micronuclei and sister chromatid exchange in cultured fibroblasts of patients with cutaneous malignant melanoma. Cancer Genet. Cytogenet. 41:1989;129-137.
19. Thompson F.H., Burgess A., Fox S., Emerson J., Taetle R., Salmon S.E. Cytogenetic abnormalities in 24 cases of stage II malignant melanoma. Cancer Genet. Cytogenet. 66:1993;164.
20. Balaban G., Herlyn M., Guerry D., Bartolo R., Koprowsky H., Clark W.H. Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet. Cytogenet. 11:1994;429-439.
21. Ozisik Y.Y., Meloni A.M., Altugonz O., Peier A., Karakousis C., Leong S.P.L. Cytogenetic findings in 21 malignant melanoma. Cancer Genet. Cytogenet. 77:1994;69-73.
22. Abend M., Rhein A., Gilbertz K.P., Blakely W.F., Van Beuningen D. Correlation of micronucleus and apoptosis assays with reproductive cell death. Int. J. Radiat. Biol. 673:1995;315-326.
23. Slominski A., Paus R., Mihm M.C. Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res. 18:1998;3709-3715.